Chemotherapy, AdjuvantBreast NeoplasmsRadiotherapy, AdjuvantNeoplasm Recurrence, LocalTamoxifenPrognosisAdjuvants, ImmunologicCombined Modality TherapyLymphatic MetastasisNeoplasm StagingMastectomy, SegmentalAntineoplastic Agents, HormonalMastectomyAxillaReceptors, EstrogenDisease-Free SurvivalTreatment OutcomeSurvival AnalysisAntineoplastic Combined Chemotherapy ProtocolsReceptors, ProgesteroneReceptor, erbB-2Survival RateFreund's AdjuvantFollow-Up StudiesRetrospective StudiesMultivariate AnalysisCohort StudiesAntineoplastic AgentsNeoadjuvant TherapyAdjuvants, PharmaceuticNeoplasm MetastasisDermatologic AgentsClinical Trials as TopicFluorouracilLiver NeoplasmsMetastasectomyPsoriasisCarcinoma, Renal CellKidney NeoplasmsMethotrexateAntibodies, Monoclonal, HumanizedCyclophosphamideAntineoplastic ProtocolsMelanomaRandomized Controlled Trials as TopicPanuveitisDoxorubicinAromatase InhibitorsTumor Markers, BiologicalFluocinolone AcetonideAnthracyclinesKaplan-Meier EstimatePhenylurea CompoundsBone NeoplasmsNiacinamideAluminum HydroxideDisease ProgressionBenzenesulfonatesLung NeoplasmsCarcinoma, HepatocellularBiological TherapyRosaceaNeoplastic Cells, CirculatingTime FactorsAntibodies, MonoclonalLymph Node ExcisionMolecular Targeted TherapySkin NeoplasmsLymph NodesProportional Hazards ModelsAngiogenesis InhibitorsLymphatic IrradiationAdenocarcinomaFloxuridineTaxoidsDeoxycytidineCranial IrradiationConsensus Development Conferences as TopicImmunotherapyPyrrolesRadiotherapyAdministration, TopicalImmunizationColorectal NeoplasmsSentinel Lymph Node BiopsyNephrectomyCarcinomaProspective StudiesDrug Administration SchedulePredictive Value of TestsNeuroendocrine TumorsInfusions, Intra-ArterialCentral Nervous System NeoplasmsMedical OncologySarcomaPancreatic NeoplasmsCisplatinPreoperative CareRecurrenceNeoplasm Invasiveness